Life sciences Women’s health biopharmaceutical company ObsEva receives USD 500 million 10 August 2021
Life sciences Lonza invests CHF 650 million in a new large-scale production facility in Visp 10 May 2021
Life sciences Life sciences Lonza invests CHF 200 million in a new production facility in Visp 27 April 2021
Life sciences Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp 12 April 2021
Life sciences Medtech company MedAlliance raises over USD 50 million to commercialize drug-eluting balloons 24 March 2021
Life sciences Pharmaceutical and biotech expert ZETA opens new subsidiary in Switzerland 8 February 2021